Omeicos Opthalmics names first CEO

Omeicos Opthalmics, a subsidiary of German biotech Omeicos Therapeutics, has named Alexander Gebauer as its first chief executive and chairman of the board.

The German scientist, who has previously held a variety of senior R&D roles with companies including the French pharma major Sanofi (Euronext: SAN), will also take on the role of clinical development head for the larger Omeicos firm, joining the board in the process.

Dr Gebauer commented, “Omeicos has tremendous potential to make a fundamental change in the treatment of cardiovascular and ophthalmic diseases. I look forward to building on the company’s successes that have been achieved to date, capitalizing on expertise in the cardiology and ophthalmology fields which I gained in my previous roles.”